Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.

被引：0

作者：

Antolin, Silvia

Garcia-Caballero, Lucia

Reboredo, Cristina

Molina Diaz, Aurea

Mosquera, Joaquin

Vazquez-Boquete, Angel

Gallego, Rosalia

Paz Santiago, Maria

Concha, Angel

Eva Perez, Maria

Calvo, Lourdes

Garcia-Caballero, Tomas

机构：

[1] Univ Hosp A Coruna CHUAC SERGAS, Med Oncol Dept, La Coruna, Spain

[2] Sch Med & Dent, Dept Morphol Sci, Santiago De Compostela, Spain

[3] A Coruna Univ Hosp, Dept Med Oncol, Breast Unit, La Coruna, Spain

[4] Complexo Hosp Univ A Coruna, La Coruna, Spain

[5] Santiago Compostela Univ Hosp, Dept Pathol, Santiago De Compostela, Spain

[6] Santiago Compostela Univ, Sch Med & Dent, Dept Morphol Sci, Santiago De Compostela, Spain

[7] A Coruna Univ Hosp, Dept Pathol, Breast Unit, La Coruna, Spain

[8] A Coruna Univ Hosp, La Coruna, Spain

[9] Santiago Compostela Univ, Sch Med & Dent, Dept Morphol Sci, La Coruna, Spain

来源：

关键词：

Breast cancer; FISH; HER2; amplification; trastuzumab; neoadjuvant therapy; pathological complete response;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e12641

引用

页数：2